Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV) Shares Purchased by Physician Wealth Solutions Inc.

Physician Wealth Solutions Inc. increased its stake in shares of Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIVFree Report) by 0.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 36,788 shares of the company’s stock after purchasing an additional 134 shares during the period. Vanguard Intermediate-Term Bond ETF makes up approximately 1.4% of Physician Wealth Solutions Inc.’s holdings, making the stock its 21st biggest holding. Physician Wealth Solutions Inc.’s holdings in Vanguard Intermediate-Term Bond ETF were worth $2,749,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Montag A & Associates Inc. increased its holdings in Vanguard Intermediate-Term Bond ETF by 112.9% during the 4th quarter. Montag A & Associates Inc. now owns 379 shares of the company’s stock worth $28,000 after purchasing an additional 201 shares during the last quarter. Coastline Trust Co purchased a new stake in Vanguard Intermediate-Term Bond ETF during the 3rd quarter worth approximately $32,000. Newbridge Financial Services Group Inc. purchased a new stake in Vanguard Intermediate-Term Bond ETF during the 4th quarter worth approximately $45,000. Financial Connections Group Inc. increased its holdings in Vanguard Intermediate-Term Bond ETF by 32.0% during the 4th quarter. Financial Connections Group Inc. now owns 681 shares of the company’s stock worth $50,000 after purchasing an additional 165 shares during the last quarter. Finally, Cape Investment Advisory Inc. increased its holdings in Vanguard Intermediate-Term Bond ETF by 47.8% during the 4th quarter. Cape Investment Advisory Inc. now owns 748 shares of the company’s stock worth $56,000 after purchasing an additional 242 shares during the last quarter.

Vanguard Intermediate-Term Bond ETF Stock Performance

BIV stock opened at $76.57 on Tuesday. Vanguard Intermediate-Term Bond ETF has a 52-week low of $72.95 and a 52-week high of $78.89. The stock’s 50 day moving average is $75.00 and its two-hundred day moving average is $76.19.

Vanguard Intermediate-Term Bond ETF Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Wednesday, March 5th. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.2531 per share. The ex-dividend date is Monday, March 3rd. This is an increase from Vanguard Intermediate-Term Bond ETF’s previous dividend of $0.23.

Vanguard Intermediate-Term Bond ETF Profile

(Free Report)

Vanguard Intermediate-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 5-10 Year Government/Credit Bond Index (the Index).

Featured Stories

Want to see what other hedge funds are holding BIV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIVFree Report).

Institutional Ownership by Quarter for Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV)

Receive News & Ratings for Vanguard Intermediate-Term Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Intermediate-Term Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.